GEH200520/GEH200521 (18F)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GEH200520/GEH200521 (18F), covering 2025-11-17 to 2025-11-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies [Phase 1]